Aptamer conjugated paclitaxel and magnetic fluid loaded fluorescently tagged PLGA nanoparticles for targeted cancer therapy

Journal of Magnetism and Magnetic Materials

Volumn 344, Issue , 2013, Pages 116-123

  Aravind, Athulya ^a   Nair, Remya ^a   Raveendran, Sreejith ^a   Veeranarayanan, Srivani ^a   Nagaoka, Yutaka ^a   Fukuda, Takahiro ^a   Hasumura, Takahashi ^a   Morimoto, Hisao ^a   Yoshida, Yasuhiko ^a   Maekawa, Toru ^a   Kumar, D Sakthi ^a  

^a TOYO UNIVERSITY   (Japan)

Author keywords

AS1411 aptamer; Cancer therapy; Magnetic fluid; Nanodrug delivery; Paclitaxel; PLGA nanoparticles

Indexed keywords

BINS; CELL CULTURE; CELL MEMBRANES; CELLS; CHEMOTHERAPY; CONJUGATED POLYMERS; CONTROLLED DRUG DELIVERY; CROSSLINKING; CYTOLOGY; DISEASES; DRUG INTERACTIONS; DRUG PRODUCTS; EMULSIFICATION; MAGNETIC FLUIDS; MAGNETIC LEVITATION VEHICLES; MAGNETISM; NANOMAGNETICS; NANOPARTICLES; ONCOLOGY; ORGANIC POLYMERS; SYNTHESIS (CHEMICAL); TUMORS;

APTAMERS; CANCER THERAPY; NANODRUG DELIVERY; PACLITAXEL; PLGA NANOPARTICLES;

TARGETED DRUG DELIVERY;

EID: 84885106615     PISSN: 03048853     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmmm.2013.05.036     Document Type: Article

References (42)

1. T. Chen, M.I. Shukoor, R. Wang, et al, Smart multifunctional nanostructure for targeted cancer chemotherapy and magnetic resonance imaging, ACS Nano 5 (2011) 7866-7873.
2. G. Poste, R. Kirsh, Site-specific (targeted) drug delivery in cancer therapy, Nature Biotechnology 1 (1983) 869-878. (Pubitemid 14176829)
3. O.-M. Koo, I. Rubinstein, H. Onyuksel, Role of nanotechnology in targeted drug delivery and imaging: a concise review, Nanomedicine: Nanotechnology, Biology and Medicine 1 (2005) 193-212. (Pubitemid 43963632)
4. J. Kim, J.E. Lee, S. Lee, et al, Designed fabrication of a multifunctional polymer nanomedical platform for simultaneous cancer-targeted imaging and magnetically guided drug delivery, Advanced Materials 20 (2008) 478-483.
5. S. Santra, R.P. Bagwe, D. Dutta, et al, Synthesis and characterization of fluorescent, radio-opaque, and paramagnetic silica nanoparticles for multimodal bioimaging applications, Advanced Materials 17 (2005) 2165-2169. (Pubitemid 41338513)
6. J.S. Kim, W.J. Rieter, K.M.L. Taylor, et al, Self-assembled hybrid nanoparticles for cancer-specific multimodal imaging, Journal of the American Chemical Society 129 (2007) 8962-8963. (Pubitemid 47171835)
7. W.J. Rieter, J.S. Kim, K.M.L. Taylor, et al, Hybrid silica nanoparticles for multimodal imaging, Angewandte Chemie International Edition 46 (2007) 3680-3682. (Pubitemid 46981247)
8. W.J. Rieter, K.M.L. Taylor, H. An, et al, Nanoscale metal-organic frameworks as potential multimodal contrast enhancing agents, Journal of the American Chemical Society 128 (2006) 9024-9025. (Pubitemid 44078972)
9. J.-L. Bridot, A.-C. Faure, S. Laurent, et al, Hybrid gadolinium oxide nanoparticles: multimodal contrast agents for in vivo imaging, Journal of the American Chemical Society 129 (2007) 5076-5084. (Pubitemid 46651385)
10. Z. Liu, P. Koczera, D. Doleschel, et al, Versatile synthetic strategies for PBCA-based hybrid fluorescent microbubbles and their potential theranostic applications to cell labelling and imaging, Chemical Communications (2012), http://dx.doi.org/10.1039/c2cc18048k.
11. Y. Wang, Y.W. Ng, Y. Chen, et al, Formulation of superparamagnetic iron oxides by nanoparticles of biodegradable polymers for magnetic resonance imaging, Advanced Functional Materials 18 (2008) 308-318. (Pubitemid 351212312)
12. J. Kim, S. Park, J.E. Lee, et al, Designed fabrication of multifunctional magnetic gold nanoshells and their application to magnetic resonance imaging and photothermal therapy, Angewandte Chemie International Edition 45 (2006) 7754-7758. (Pubitemid 44871335)
13. S. Kim, T.Y. Ohul-Chanskyy, H.E. Pudavar, et al, Organically modified silica nanoparticles co-encapsulating photosensitizing drug and aggregation-enhanced two-photon absorbing fluorescent dye aggregates for two-photon photodynamic therapy, Journal of the American Chemical Society 129 (2007) 2669-2675. (Pubitemid 46364075)
14. Z. Medarova, W. Pham, C. Farrar, et al, In vivo imaging of siRNA delivery and silencing in tumors, Nature Medicine 13 (2007) 372-377. (Pubitemid 46376679)
15. N. Nasongkla, E. Bey, J. Ren, et al, Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems, Nano Letters 6 (2006) 2427-2430. (Pubitemid 46076928)
16. A.S. Lubbe, C. Bergemann, H. Riess, et al, Clinical experiences with magnetic drug targeting: a phase I study with 4′-epidoxorubicin in 14 patients with advanced solid tumors, Cancer Research 56 (1996) 4686-4693. (Pubitemid 26338071)
17. S. Acharya, S.K. Sahoo, PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect, Advanced Drug Delivery Reviews 63 (2011) 170-183.
18. A. Juríková, K. Csach, M. Koneracká, et al., Magnetic polymer nanospheres for anticancer drug targeting, Journal of Physics: Conference Series 200 (2010) 122004.
19. M. Koneracká, M. Múčková, V. Závišová, et al., Encapsulation of anticancer drug and magnetic particles in biodegradable polymer nanospheres, Journal of Physics 20 (2008) 204151.
20. A.K.A. Silva, E.L. Silva, A.S. Carrico, et al, Magnetic carriers: a promising device for targeting drugs into the human body, Current Pharmaceutical Design 13 (2007) 1179-1185. (Pubitemid 46739342)
21. A.S. Lübbe, C. Bergemann, W. Huhnt, et al., Preclinical experiences with magnetic drug targeting: tolerance and efficacy, Cancer Research 56 (1996) 4694-4701. (Pubitemid 26338072)
22. C. Alexiou, W. Arnold, R.J. Klein, et al, Locoregional cancer treatment with magnetic drug targeting, Cancer Research 60 (2000) 6641-6648.
23. M.W. Wilson, R.K. Kerlan, N.A. Fidelman, et al, Hepatocellular carcinoma: regional therapy with a magnetic targeted carrier bound to doxorubicin in a dual mr imaging/conventional angiography suite - initial experience with four patients, Radiology 230 (2004) 287-293. (Pubitemid 37549815)
24. C. Alexiou, R. Jurgons, R. Schmid, et al, In vitro and in vivo investigations of targeted chemotherapy with magnetic nanoparticles, Journal of Magnetism and Magnetic Materials 293 (2005) 389-393. (Pubitemid 40608956)
25. H.S. Cho, Z. Dong, G.M. Pauletti, et al, Fluorescent, superparamagnetic nano-spheres for drug storage, targeting, and imaging: a multifunctional nanocarrier system for cancer diagnosis and treatment, ACS Nano 4 (2010) 5398-5404.
26. M. Dunne, O.I. Corrigan, Z. Ramtoola, Influence of particle size and dissolution conditions on the degradation properties of polylactide-co-glycolide particles, Biomaterials 21 (2000) 1659-1668. (Pubitemid 30347308)
27. A.C.R. Grayson, M.J. Cima, R. Langer, Size and temperature effects on poly (lactic-co-glycolic acid) degradation and microreservoir device performance, Biomaterials 26 (2005) 2137-2145. (Pubitemid 39575357)
28. A.M. Reed, D.K. Gilding, Biodegradable polymers for use in surgery-poly (glycolic)/poly(lactic acid) homo and copolymers: 2. In vitro degradation, Polymer 22 (1981) 494-498. (Pubitemid 11499831)
29. A. Aravind, S.H. Varghese, S. Veeranarayanan, et al, Aptamer-labeled PLGA nanoparticles for targeting cancer cells. Cancer Nanotechnology. (2012) 10.1007/s12645-011-0024-6.
30. J.M. Koziara, P.R. Lockman, D.D. Allen, et al, Paclitaxel nanoparticles for the potential treatment of brain tumors, Journal of Controlled Release 99 (2004) 259-269. (Pubitemid 39222111)
31. H.-F. Liang, C.-T. Chen, S.-C Chen, et al., Paclitaxel-loaded poly(Lglutamic acid)-poly(lactide) nanoparticles as a targeted drug delivery system for the treatment of liver cancer, Biomaterials 27 (2006) 2051-2059. (Pubitemid 41759499)
32. A. Jordan, R. Scholz, P. Wust, et al, Magnetic fluid hyperthermia (MFH): cancer treatment with Ac magnetic field induced excitation of biocompatible super-paramagnetic nanoparticles Journal of Magnetism and Magnetic Materials 201 (1999) 413-419.
33. R. Hergt, S. Dutz, R. Muller, et al, Magnetic particle hyperthermia: nanopar-ticle magnetism and materials development for cancer therapy, Journal of Physics: Condensed Matter 18 (2006) 2919.
34. T. Neuberger, B. Schopf, H. Hofmann, et al, Superparamagnetic nanoparticles for biomedical applications: possibilities and limitations of a new drug delivery system, Journal of Magnetism and Magnetic Materials 293 (2005) 483-496. (Pubitemid 40608969)
35. A. Mukerjee, J.K. Vishwanatha, Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy, Anticancer Research 29 (2009) 3867-3875.
36. P.J. Bates, D.A Laber, Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer, Experimental and Molecular Pathology 86 (2009) 151-164.
37. S. Soundararajan, L. Wang, V. Sridharan, et al, Plasma membrane nucleolin is a receptor for the anticancer aptamer AS1411 in MV4-11 leukemia cells, Leukemia and Lymphoma 76 (2009) 984-991.
38. L. Zhao, Y. Wang, B. Yang, et al, Magnetic nanocomposite devices for cancer thermochemotherapy, in: Boreddy Reddy (Ed.), Advances in Nanocomposites-Synthesis, Characterization and Industrial Applications, InTech Publishers, 2011, ISBN: 978-953-307-165-7, http://dx.doi.org/10.5772/15344. Available from: /http://www.intechopen.com/books/advances-in-nanocomposites- synthesis-characterization-and-industrial-applications/magnetic-nanocomposite- devices-for-cancer-thermochemotherapyS.
39. B.G. Nair, Y. Nagaoka, H. Morimoto, et al, Aptamer conjugated magnetic nanoparticles as nanosurgeons, Nanotechnology 21 (2010) 455102.
40. M.S. Cartiera, E.C. Ferreira, C. Caputo, et al, Partial correction of cystic fibrosis defects with PLGA nanoparticles encapsulating curcumin, Molecular Pharmaceutics 276 (2010) 675.
41. S.I. Thamake, S.L. Raut, P. Ranjan, et al, Surface functionalization of PLGA nanoparticles by non-covalent insertion of a homo-bifunctional spacer for active targeting in cancer therapy, Nanotechnology 22 (2011) 035101.
42. L. Zhang, J.M. Chan, F.X. Gu, et al, Self-assembled lipid-polymer hybrid nanoparticles: a robust drug delivery platform, ACS Nano 2 (2008) 1696-1702.